GlassScriptPhysician profile
Suresh Sharma
NPI 1922394899
$14,928.49
in general payments reported to CMS, 2019-2025
35 companies · $1,839 in 2025
The $1,839 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,062 · 2020: $1,438 · 2021: $1,646 · 2022: $4,752 · 2023: $1,742 · 2024: $1,448 · 2025: $1,839.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,949 · Travel and Lodging: $550 · Consulting Fee: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,949.25 |
| Travel and Lodging | $550.20 |
| Consulting Fee | $530.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,815.70 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Inspiris Resilia Aortic Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $4,490.26 | 2019-2025 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $783.00 | 2022-2025 | Symplicity G3, Onyx Frontier, Resolute Onyx |
| Novartis Pharmaceuticals Corporation | $608.51 | 2019-2025 | |
| Amgen INC. | $510.28 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $376.53 | 2022-2024 | Navitor, Portico |
| Pfizer INC. | $338.92 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $305.68 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $219.88 | 2019-2024 | Xarelto |
| Asahi Intecc USA, INC. | $158.01 | 2019-2023 | Asahi Ptca Guide Wire |
| Philips North America LLC | $135.47 | 2023-2024 | (Ck4) Mcot, (Ck7) Extended Holter |
| Abiomed | $125.72 | 2021 | |
| Heartflow, INC. | $124.24 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.38 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $88.37 | 2021-2025 | Verquvo, Capvaxive |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.